From ANA-screening to antigen-specificity: An EASI-survey on the daily practice in European countries

Clinical and Experimental Rheumatology

Volumn 32, Issue 4, 2014, Pages 539-546

  Damoiseaux, Jan ^a   Agmon Levin, Nancy ^b   van Blerk, Marjan ^c   Chopyak, Valentyna ^d   Eriksson, Catharina ^e   Heijnen, Ingmar ^f   Herold, Manfred ^g   Høgåsen, Kolbjørn ^h   Musset, Lucile ⁱ   Radice, Antonella ^j   De Sousa, Maria José Rego ^k   Viander, Markku ^l   Shoenfeld, Yehuda ^b,m  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SHEBA MEDICAL CENTER   (Israel)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^e UMEÅ UNIVERSITY   (Sweden)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h Sykehuset Innlandet Trust   (Norway)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j SAN CARLO BORROMEO HOSPITAL   (Italy)

^k HOSPITAL FERNANDO FONSECA   (Portugal)

^l UNIVERSITY OF TURKU   (Finland)

^m TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

Algorithm; Anti nuclear antibodies; Extractable nuclear antigens; Harmonisation; Systemic autoimmune rheumatic diseases

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; ENA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL EVALUATION; CLINICAL PRACTICE; EUROPE; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE;

ALGORITHMS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; EUROPE; HEALTH CARE SURVEYS; HUMANS; LABORATORIES; LABORATORY PROFICIENCY TESTING; OBSERVER VARIATION; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; RHEUMATOLOGY; SEROLOGIC TESTS;

EID: 84904915993     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
2. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
3. DAMOISEAUX JGMC, COHEN TERVAERT JW: From ANA to ENA: how to proceed? AutoimmunRev 2006; 5: 10-7.
4. MERONI PL, SCHUR PH: ANA screening: an old test with new recommendations. Ann Rheum Dis 2010; 69: 1420-2.
5. SHOENFELD Y, CERVERA R, HAASS M et al.: EASI-the European Autoimmunity StandardisationInitiative. Ann NY Acad Sci 2007; 1109: 138-44.
6. DAMOISEAUX J, COHEN TERVAERT JW, DERKSEN R et al.: Autoantibody standardizationin the Netherlands: the past, the present, and the future. Ann NY Acad Sci 2009; 1173: 10-4.
7. DAMOISEAUX J, BAKKER-JONGES L, COHENTERVAERT JW et al.: Laboratoriumdiagnostiekvan ANA, anti-ds-DNA-en anti-ENA-antistoffen: aanbevelingen naar aanleidingvan een enquête. Ned Tijdschr Klin Chem Labgeneesk 2010; 35: 234-9.
8. NOSSENT H, REKVIG OP: Antinuclear antibodyscreening in this new millennium: farewellto the microscope? Scand J Rheumatol 2001; 30: 123-6.
9. DAHLE C, SKOGH T, ABERG AK, JALAL A, OLCÉN P: Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefitof adding antigen-specific assays to immunofluorescencemicroscopy. J Autoimmun 2004; 22: 241-8.
10. FRITZLER MJ: The antinuclear antibody test: last or lasting gasp? Arthritis Rheum 2011; 63: 19-22.
11. TAN EM, FELTKAMP TEW, SMOLEN JS et al.: Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
12. OP DE BEÉCK K, VERMEERSCH P, VERSCHUEREN P et al.: Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011; 10: 801-8.
13. OP DE BEÉCK K, VERMEERSCH P, VERSCHUERENP et al.: Antinuclear antibody detection by automated multiplex immunoassayin untreated patients at the time of diagnosis. Autoimmun Rev 2012; 12: 137-43.
14. HAHN BH: Antibodies to DNA. N Eng J Med 1998; 338: 1359-69.
15. KAVANAUGH AF, SOLOMON DH, the AmericaAnCcollege of RrheumaAtology aAd hoc committee on immunologic testing guidelines: Guidelines for immunologiclaboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002; 47: 546-55.
16. GHIRARDELLO A, VILLALTA D, MOROZZI G et al.: Diagnostic accuracy of currently availableanti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 2011; 29: 50-6.
17. ANTICO A, PLATZGUMMER S, BASSETTI D, BIZZARO N, TOZZOLI R, VILLALTA D: Diagnosingsystemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternativeto the Farr technique and the Chithidialuciliae immunofluorescence test. Lupus 2010; 19: 906-12.
18. SCHULTE-PELKUM J, FRITZLER M, MAHLER M: Latest update on the Ro/SS-A autoantibodysystem. Autoimmun Rev 2009; 8: 632-7.
19. FRIEDMAN DM, RUPEL A, BUYON JP: Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 2007; 9: 101-8.
20. SHIBOSKI SC, SHIBOSKI CH, CRISWELL L et al.: American College of Rheumatology classificationcriteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012; 64: 475-87.
21. RETAMOZO S, AKASBI M, BRITO-ZERÓN P et al.: Anti-Ro52 antibody testing influences the classification and clinical characterisationof primary Sjögren's syndrome. Clin Exp Rheumatol 2012; 30: 686-92.
22. POPOVIC K, BRAUNER S, EK M, WAHREN-HERLENIUS M, NYBERG F: Fine specificity of the Ro/SSA autoantibody response in relationto serological and clinical findings in 96 patients with self-reported cutaneous symptomsinduced by the sun. Lupus 2007; 16: 10-7.
23. AGMON-LEVIN N, DAMOISEAUX J, KALLENBERG C et al.: International recommendationsfor the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014; 73: 17-23.
24. GHIRARDELLO A, BENDO R, RAMPUDDA ME, BASSI N, ZAMPIERI S, DORIA A: Commercialblot assays in the diagnosis of systemicrheumatic diseases. Autoimmun Rev 2009; 8: 645-9.
25. MEHRA S, WALKER J, PATTERSON K, FRITZLER MJ: Autoantibodies in systemic sclerosis. Autoimmun Rev 2013; 12: 340-54.
26. BONROY C, SMITH V, vaAn STEENDAM K et al.: Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnosticperformance and correlation with conventional techniques. Clin Exp Rheumatol 2012; 30: 748-55.